台股 » 個股 » 浩鼎 » 籌碼相關 » 券商分點績效

浩鼎

(4174)
可現股當沖
  • 股價
    61.0
  • 漲跌
    ▼0.1
  • 漲幅
    -0.16%
  • 成交量
    514
  • 產業
    上櫃 生技醫療類股
  • 218人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
浩鼎 (4174)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/06/21     後一日»

券商獲利排行 - 2024/06/21

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  0.96%12.40.412-1912161.661.261.661
  0.48%5.305.3-1801861.3061.361
  1.61%505-5056206261
  1.46%4.54.5005561.661.16261
  0.25%2.902.9-1901961.2061.261
  0.81%2.502.5-50561.5061.561
  0.34%2.102.1-1001061.2061.261
  0.49%2.102.177060.760.7061
  1.63%22002261.5616261
  0.65%202-50561.4061.461
  0.62%1.90.11.8-32561.661.661.661
  0.77%1.90.31.6-31461.561.361.661
  0.73%1.801.8-40461.5061.561
  1.47%1.81.8002261.260.761.661
  1.45%1.801.8-10261.961.661.961
  0.49%1.801.8-60661.3061.361
  0.13%1.83.7-1.95231861.561.461.661
  1.29%1.601.6-20261.8061.861
  1.29%1.601.6-20261.8061.861
  0.37%1.60.21.4-61761.26161.261
  1.13%1.401.4-20261.7061.761
  2.12%1.31.3001161.460.76261
  0.90%1.10.90.31216160.861.661
  0.60%1.101.1-30361.4061.461
  0.06%101-260266106161
  0.33%10155060.860.8061
  0.81%101-20261.5061.561
  1.46%0.90.9001161.661.16261
  0.29%0.90.60.33516160.961.561
  0.67%0.800.8-20261.4061.461
  0.65%0.800.8-20261.4061.461
  0.65%0.800.8-20261.4061.461
  0.57%0.700.7-20261.4061.461
  0.57%0.700.7-20261.4061.461
  0.16%0.600.666060.960.9061
  0.48%0.60.6002161.26161.561
  0.20%0.50.30.23416160.961.261
  0.16%0.50.10.4-41561.16161.161
  0.81%0.500.5-10161.5061.561
  0.11%0.400.466060.960.9061
  0.33%0.400.422060.860.8061
  0.33%0.40.4002261.16161.261
  0.22%0.400.433060.960.9061
  0.65%0.400.4-10161.4061.461
  0.02%0.4-2.22.6-28144261.161.361.161
  0.49%0.30.300116160.861.161
  0.49%0.300.3-10161.3061.361
  0.49%0.300.311060.760.7061
  0.49%0.300.3-10161.3061.361
  0.08%0.300.3560616161.161

券商虧損排行 - 2024/06/21

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.42%-14.90-14.91717061.961.9061
  -1.45%-6.30-6.377061.961.9061
  -0.97%-5.40-5.489061.661.661.161
  -0.28%-4.2-3.8-0.4-817256161.260.961
  -0.14%-3.8-3.90.1-2424461.161.261.161
  -0.06%-3.6-4.61-64349861.161.26161
  -0.97%-3.60-3.666061.661.6061
  -0.81%-30-366061.561.5061
  -0.68%-2.50-2.566061.461.4061
  -0.16%-20-22020061.161.1061
  -0.81%-20-244061.561.5061
  -0.08%-1.90-1.9-400406106161
  -0.37%-1.80-1.888061.261.2061
  -1.30%-1.6-1.6002261.461.86161
  -0.22%-1.50-1.51111061.161.1061
  -1.13%-1.40-1.422061.761.7061
  -0.20%-1.2-0.4-0.8810261.161.160.961
  -0.36%-1.10-1.155061.261.2061
  -0.81%-10-122061.561.5061
  -1.63%-1-1001161.361.860.861
  -0.37%-0.90-0.944061.261.2061
  -1.46%-0.90-0.901061.861.961.161
  -0.16%-0.80-0.888061.161.1061
  -1.29%-0.80-0.811061.861.8061
  -0.38%-0.70-0.733061.261.2061
  -0.16%-0.60-0.666061.161.1061
  -0.33%-0.60-0.623061.261.260.961
  -0.98%-0.6-0.6001161.161.460.861
  -0.49%-0.60-0.622061.361.3061
  -0.49%-0.60-0.622061.361.3061
  -0.20%-0.50-0.544061.161.1061
  -0.81%-0.50-0.511061.561.5061
  -0.81%-0.50-0.511061.561.5061
  -0.16%-0.4-0.4004461.461.461.361
  -0.33%-0.40-0.422061.261.2061
  -0.33%-0.40-0.422061.261.2061
  -0.33%-0.40-0.422061.261.2061
  -0.65%-0.40-0.411061.461.4061
  -0.65%-0.40-0.411061.461.4061
  -0.16%-0.40-0.444061.161.1061
  -0.58%-0.40-0.411061.461.4061
  -0.05%-0.30-0.3101006161061
  -0.49%-0.30-0.311061.361.3061
  -0.49%-0.30-0.311061.361.3061
  -0.49%-0.30-0.311061.361.3061
  -0.49%-0.3-0.3001160.96160.761
  -0.25%-0.30-0.322061.261.2061
  -0.25%-0.3-0.1-0.112161.161.26161
  -0.33%-0.20-0.201061.261.261.161
  -0.33%-0.2-0.2001161.161.26161
〈浩鼎股東會〉聚焦ADC產品線 下半年擬辦理現增Anue鉅亨-5天前
AACR 2024年會 浩鼎將發表ADC藥物臨床前數據Anue鉅亨-2024/03/18
浩鼎乳癌針劑新藥三期臨床期中分析 獲可繼續執行建議Anue鉅亨-2024/01/31
浩鼎 相關文章